Free Trial
CVE:NDVA

Indiva (NDVA) Stock Price, News & Analysis

Indiva logo
C$0.03 -0.01 (-14.29%)
As of 06/12/2024

About Indiva Stock (CVE:NDVA)

Key Stats

Today's Range
C$0.03
C$0.04
50-Day Range
C$0.03
C$0.03
52-Week Range
C$0.02
C$0.13
Volume
558,384 shs
Average Volume
119,038 shs
Market Capitalization
C$5.86 million
P/E Ratio
N/A
Dividend Yield
4.04%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NDVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indiva and its competitors with MarketBeat's FREE daily newsletter.

NDVA Stock News Headlines

Indiva Ltd Average Daily Volume (3m)
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Indiva Limited (NDVA-H.V)
NDVA:CA Indiva Limited
Indiva Limited (NDVAF) Q4 2023 Earnings Call Transcript
See More Headlines

NDVA Stock Analysis - Frequently Asked Questions

Indiva's stock was trading at C$0.03 at the beginning of the year. Since then, NDVA stock has increased by 0.0% and is now trading at C$0.03.

Shares of NDVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Indiva investors own include Meta Platforms (META), Canopy Growth (CGC), 22nd Century Group (XXII), AcelRx Pharmaceuticals (ACRX), Acasti Pharma (ACST), Curaleaf (CURLF) and Fortress Biotech (FBIO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:NDVA
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$4.92 million
Net Margins
-13.09%
Pretax Margin
N/A
Return on Equity
-544.76%
Return on Assets
-3.51%

Debt

Debt-to-Equity Ratio
5,899.22
Current Ratio
0.72
Quick Ratio
0.52

Sales & Book Value

Annual Sales
C$37.57 million
Price / Sales
0.16
Cash Flow
C$0.01 per share
Price / Cash Flow
5.20
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
195,490,000
Free Float
N/A
Market Cap
C$5.86 million
Optionable
Not Optionable
Beta
1.12
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (CVE:NDVA) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners